Friday, August 3, 2018

CBS board hires two law firms as fallout over harassment allegations grows

The CBS board of directors met again on Wednesday and agreed to hire two law firms "to conduct a full investigation of the allegations in recent press reports about Chairman and CEO Leslie Moonves, CBS News and cultural issues at all levels of CBS."

Translation: This is going to take awhile.

The board said a special committee will "help facilitate the investigation," and "Moonves will have no role in the investigation." The law firms are Covington & Burling and Debevoise & Plimpton.

Moonves remains CEO, but note this language in the press release: "The Board took no further action at this meeting pending discussion with counsel as to appropriate next steps. The Board noted that it takes these allegations seriously and is committed to acting in the best interest of the Company and all of its shareholders, and is confident that the employees of CBS will continue to perform at a high level as this process unfolds."

What will Moonves say?

Before the board announcement, Fox's Charlie Gasparino wrote: "CBS executives and employees remain on edge as their CEO, Les Moonves, prepares for one of the most important days during his long, and mostly illustrious career: Thursday's earnings conference call with Wall Street analysts..."

The call is at 4:30pm ET. Moonves WILL speak on the call. Per Dylan Byers, he is "prepared to address questions regarding the recent allegations of sexual misconduct, as well as the ongoing legal battle with Shari Redstone over the future of the company, a source with knowledge of the matter says..."

What about "60 Minutes?"

Ronan Farrow's bombshell story about alleged harassment at CBS came out while "60 Minutes" staffers were enjoying their annual summer break. But now the vacation is over... The staffers are starting to come back to work... And they are wondering who's in charge.

"60" executive producer Jeff Fager firmly denied the allegations that he made unwanted advances and enabled harassment by others in positions of power at the newsmag. But the accusations of misconduct came as no surprise to "60 Minutes" vets, who had long suspected that stories might be coming. Now CBS staffers are wondering if Fager will be replaced.

Here are the key details from my new story:

-- Multiple staffers told me that they don't see how Fager can remain in the job. The speculation ramped up on Wednesday when some, though not all, "60" staffers returned to work.

-- In response to Q's, Fager told me, "I am handling everything and today was our first day back but I'm not in the office until Monday."

-- The law firm Proskauer Rose is conducting a review for CBS News. The Fager allegations are part of the review. It's possible that Fager will be sidelined until the law firm's work is complete, a source familiar with the matter said, but no decision has been shared with staffers yet.

Sign up for Reliable Sources, Stelter's indispensable read on the media and journalism

Intel from sources...

Fager has both supporters and detractors within CBS News. One thing I picked up from sources: There's a lot of uncertainty about who would replace him at the helm of the program. AND the situation is exceedingly delicate because Moonves' future at CBS is also up in the air. In a way, the fates of Moonves and Fager are intertwined. Because both men have been publicly accused of wrongdoing, several sources suggested it would be strange to see action taken against one, but not the other...

More CBS updates

-- On Wednesday came word that USC's Annenberg School will drop Moonves' name from its media center while the CBS investigation is underway... Plus, he was suspended from the USC School of Cinematic Arts Board of Councilors... and he recused himself from the Commission on Eliminating Sexual Harassment and Advancing Equality in the Workplace...

-- Shares in CBS had a relatively calm day... The stock closed down 0.23% on Wednesday...

-- Read Kim Masters' latest for the mood in Hollywood.

Sunday, July 22, 2018

Head-To-Head Analysis: American Public Education (APEI) & China Distance Education (DL)

American Public Education (NASDAQ: APEI) and China Distance Education (NYSE:DL) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.

Risk and Volatility

Get American Public Education alerts:

American Public Education has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, China Distance Education has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500.

Insider & Institutional Ownership

94.1% of American Public Education shares are owned by institutional investors. Comparatively, 22.1% of China Distance Education shares are owned by institutional investors. 3.2% of American Public Education shares are owned by company insiders. Comparatively, 41.6% of China Distance Education shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares American Public Education and China Distance Education’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
American Public Education 7.10% 7.90% 6.71%
China Distance Education 3.94% 9.25% 2.65%

Analyst Ratings

This is a summary of recent recommendations for American Public Education and China Distance Education, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Public Education 0 3 1 0 2.25
China Distance Education 0 0 0 0 N/A

American Public Education currently has a consensus price target of $39.33, suggesting a potential downside of 11.91%. Given American Public Education’s higher probable upside, analysts clearly believe American Public Education is more favorable than China Distance Education.

Valuation & Earnings

This table compares American Public Education and China Distance Education’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
American Public Education $299.25 million 2.45 $21.12 million $1.29 34.61
China Distance Education $130.99 million 1.90 $14.93 million N/A N/A

American Public Education has higher revenue and earnings than China Distance Education.

Summary

American Public Education beats China Distance Education on 8 of the 12 factors compared between the two stocks.

American Public Education Company Profile

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education. The company operates through two segments, American Public Education and Hondros College of Nursing. It offers 108 degree programs and 109 certificate programs in various fields of study, including business administration, health science, technology, criminal justice, education, and liberal arts, as well as national security, military studies, intelligence, and homeland security. The company also provides diploma in practical nursing and an associate degree in nursing; and an online registered nurse to Bachelor of Science in nursing completion program. American Public Education, Inc. was founded in 1991 and is headquartered in Charles Town, West Virginia.

China Distance Education Company Profile

China Distance Education Holdings Limited provides online and offline education services, and sells related products in the People's Republic of China. It operates through three segments: Online Education Services, Business Start-Up Training Services, and The Sale of Learning Simulation Software. The company offers online professional education services in accounting, healthcare, and engineering and construction industries; and other professional education courses, such as online test-preparation courses for the national judicial examination and self-taught learners pursuing higher education diplomas or degrees, test preparation courses for university students, accounting practical skills training courses, and online language courses. Its online courses feature pre-recorded audio-video lectures taught by experts; and other content, such as course outlines, exercise questions, mock exams, and frequently asked questions and answers. The company's online lectures are supplemented by its proprietary Learning Management System, which tracks individual study progress, records course notes, and collects incorrectly answered questions. As of September 30, 2017, it operated 25 Websites, including its primary Website cdeledu.com. In addition, the company operates an Open Learning Platform, a proprietary education platform to share educational content and deliver live courses online; and sells proprietary books and reference materials. Further, it provides business start-up training courses to university students, job seekers, and individuals; offline accounting and healthcare professional training, courseware production, and online platform development services; and mobile accounting, engineering and construction, healthcare, and legal courses through an app on Android and Apple iOS tablets and smart phones, as well as sells learning simulation software to the college market. The company was founded in 2000 and is based in Beijing, the People's Republic of China.

Friday, July 13, 2018

3 Money Lessons I Wish I'd Learned When I Was Younger

There are lots of important lessons to learn in life, such as change can be good, you can learn from failures, and time heals many wounds. While some lessons we learn early in life and some we don't learn at all, some we learn later than we wish we had.

That's true in the financial realm, too, and when it comes to finances, lessons learned late or not at all can be quite costly. Here are three money lessons I wish I'd learned when I was younger.

The words you should know this written on a wall with a hand holding a marker next to them.

Image source: Getty Images.

Make smart career decisions sooner

As a kid and a teenager, and, sadly, even as a college student, I didn't give too much thought to what I would do for a living or what my career would be. That probably seems fair enough for kids and teenagers, but there are some activities I could have engaged in that would have been helpful for my career. For example, I could have learned multiple languages in school, instead of mainly French. Knowing another language might have been helpful in various careers.

I could have chatted with and even interviewed lots of my friends' parents about what they did for a living and what their jobs were like. I could have explored a wider array of fields by taking more art classes, or computer programming classes, and so on.

By the time I was in college, I would have done well to think not just about what kind of job I could eventually do and would enjoy, but what kinds of jobs were likely to provide the kind of income I'd want, and the kind of income to help me reach my financial goals. By the way, I had no financial goals at the time, and some of those would have been good to have earlier rather than later. A little consideration might have had me thinking it would be nice to retire early and to own my own home in my 30s.

Start investing sooner

Another cause for lamentation is that I didn't start investing in stocks as soon as I wish I had. I didn't know how to invest, and I didn't yet realize how much wealth I could amass if I put my mind to it. After all, I had the massive benefit of time on my side. I did get my wake-up call while I was still relatively young, but I lost out on at least five or 10 years of having a growing portfolio.

Here's what a difference five or 10 years can do to a portfolio:

Growing at 8% for

$5,000 invested annually

$10,000 invested annually

$15,000 invested annually

5 years

$31,680

$63,359

$95,039

10 years

$78,227

$156,455

$234,682

15 years

$146,621

$293,243

$439,864

20 years

$247,115

$494,229

$741,344

25 years

$394,772

$789,544

$1.2 million

30 years

$611,729

$1.2 million

$1.8 million

35 years

$930,511

$1.9 million

$2.8 million

40 years

$1.4 million

$2.8 million

$4.2 million

Calculations by author.

Imagine that beginning at age 40, you sock away $10,000 per year for 25 years, and your average annual growth rate is 8%. If you retire at age 65, you'd have about $790,000. That's pretty good! (Applying the 4% rule, it would generate more than $31,000 in income in your first year of retirement.) But if you'd started five years earlier, at age 35, you'd be ending up with $1.2 million after 30 years -- that's a difference of around $400,000 in just five years. Conversely, if you'd started at age 35, you might have retired at 60 instead of 65, with that $790,000.

The example is simplified, of course. You'll probably start out able to save less than $10,000 annually, and as time goes on you can increase your annual contributions to retirement accounts. Your growth rate may be higher or lower than 8%, too. But the sooner you start, and the more you sock away (especially in your earlier years), the better.

A stack of $100 bills on a laptop keyboard next to a note that says Financial Freedom.

Image source: Getty Images.

Make the most of Roth IRAs

Finally, I wish I'd known about and started using Roth IRAs earlier. As you might recall, there are two main kinds of IRAs -- the traditional IRA and the Roth IRA. With a traditional IRA, you contribute pre-tax money, reducing your taxable income for the year, and thereby reducing your taxes. If you have taxable income of $70,000 and make a $5,000 contribution, you'll only report $65,000 in taxable income for the year. If you're in a 24% tax bracket, you can avoid paying $1,200 in tax on that $5,000 in the contribution year. The money grows in your account and is taxed at your ordinary income tax rate later -- when you withdraw it in retirement. Many of us will be in lower tax brackets in retirement, so not only is our taxation postponed, but it's often reduced. That's the tax break you get with a traditional IRA.

A Roth IRA, meanwhile, receives post-tax contributions, so your taxable income isn't reduced at all in the contribution year. If you have taxable income of $70,000 and make a $5,000 contribution, your taxable income remains $70,000 for the year.�The great thing about the Roth IRA is that if you follow the rules, your money grows in the account until you withdraw it in retirement --�tax-free.

IRA contribution limits for the tax year 2018 are $5,500, plus an extra $1,000 "catch-up" contribution for those age 50 or older, letting those folks sock away as much as $6,500 for the year. Many companies offer Roth versions of their 401(k) plans, and those are worth considering, too -- especially because contribution limits are much higher for 401(k)s. For 2018, the 401(k) contribution limit is $18,500, with an additional $6,000 allowed for those 50 and older.

Scroll up and revisit the table. Imagine that some or much of your annual retirement savings are in Roth IRAs or Roth 401(k)s. Imagine that over, say, 20 years, you accumulate $500,000 in your Roth accounts. Come retirement, you'll be able to withdraw all that money tax-free -- at a time in your life when you'll really value every dollar and be happy to not be taxed on it.

The more you learn about money throughout your life, the better off you'll likely be -- financially and otherwise. You may be able to retire early or just enjoy being not too stressed out about your finances.

Thursday, July 12, 2018

Foamix Pharmaceuticals (FOMX) Earning Somewhat Favorable Press Coverage, Report Shows

Press coverage about Foamix Pharmaceuticals (NASDAQ:FOMX) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 45.4298608245084 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Foamix Pharmaceuticals traded up $0.22, reaching $5.43, during mid-day trading on Wednesday, Marketbeat.com reports. 63,600 shares of the stock were exchanged, compared to its average volume of 122,202. The company has a market capitalization of $218.32 million, a PE ratio of -3.09 and a beta of 1.90. Foamix Pharmaceuticals has a 1 year low of $4.34 and a 1 year high of $7.45.

Get Foamix Pharmaceuticals alerts:

Foamix Pharmaceuticals (NASDAQ:FOMX) last released its quarterly earnings results on Wednesday, May 9th. The specialty pharmaceutical company reported ($0.69) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.24). The firm had revenue of $0.91 million for the quarter, compared to analysts’ expectations of $1.11 million. Foamix Pharmaceuticals had a negative return on equity of 103.64% and a negative net margin of 2,119.19%. equities research analysts predict that Foamix Pharmaceuticals will post -1.76 EPS for the current fiscal year.

A number of research analysts have recently commented on the company. HC Wainwright set a $12.00 price objective on Foamix Pharmaceuticals and gave the company a “buy” rating in a report on Tuesday, April 17th. ValuEngine upgraded Foamix Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, May 11th. Finally, Zacks Investment Research downgraded Foamix Pharmaceuticals from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $9.67.

In related news, Director Stanley Hirsch sold 6,164 shares of the firm’s stock in a transaction that occurred on Sunday, May 13th. The stock was sold at an average price of $5.09, for a total transaction of $31,374.76. Following the transaction, the director now owns 12,672 shares in the company, valued at approximately $64,500.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 6,975 shares of company stock worth $35,522 in the last 90 days. 3.30% of the stock is currently owned by company insiders.

About Foamix Pharmaceuticals

Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations primarily for the treatment of moderate-to-severe acne, moderate-to-severe papulo-pustular rosacea, and other skin conditions in the United States and Germany. Its lead product candidates include FMX101, a novel topical foam formulation of the antibiotic minocycline, which has completed a double-blind and dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus.

Insider Buying and Selling by Quarter for Foamix Pharmaceuticals (NASDAQ:FOMX)

Tuesday, July 10, 2018

Stellar Biotechnologies (SBOT) Receives Media Impact Score of 0.19

Media stories about Stellar Biotechnologies (NASDAQ:SBOT) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Stellar Biotechnologies earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 48.7369692527559 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the media stories that may have impacted Accern Sentiment’s rankings:

Get Stellar Biotechnologies alerts: 200 days simple moving average (SMA200) to Watch Flotek Industries, Inc. (NYSE:FTK), Stellar Biotechnologies, Inc … (stocksnewspoint.com) Morning Stocks You Can’t Afford to Pass Up:: Freeport-McMoRan Inc. (NYSE:FCX), Stellar Biotechnologies, Inc … (journalfinance.net) Should Investors Adjust Their Holdings in Stellar Biotechnologies, Inc. (NasdaqCM:SBOT)? Target Weight Stands at … (bedfordnewsjournal.com) Bright Stocks in Review: Bank of America Corporation (NYSE:BAC), Stellar Biotechnologies, Inc. (NASDAQ:SBOT … (journalfinance.net) Notable News Review: Telefonica, SA, (NYSE: TEF), Stellar Biotechnologies, Inc., (NASDAQ: SBOT) (globalexportlines.com)

Separately, ValuEngine upgraded shares of Stellar Biotechnologies from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 8th.

Stellar Biotechnologies traded down $0.01, hitting $1.86, during midday trading on Monday, Marketbeat reports. The company’s stock had a trading volume of 262,900 shares, compared to its average volume of 656,707. Stellar Biotechnologies has a 12 month low of $1.65 and a 12 month high of $10.85. The stock has a market cap of $6.17 million, a PE ratio of -0.54 and a beta of 0.22.

Stellar Biotechnologies Company Profile

Stellar Biotechnologies, Inc, a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market.

Insider Buying and Selling by Quarter for Stellar Biotechnologies (NASDAQ:SBOT)

Monday, July 9, 2018

Retirement plan: When is Roth not best option?

Anyone saving for retirement has probably had to decide between saving in a Roth account versus a traditional retirement account.

The biggest reason people recommend saving in a Roth account is if you think you'll have a higher income in retirement than you do now. But if you're already saving for retirement, and you intend to maintain the same quality of living, your retirement income shouldn't exceed your current income.

Moreover, comparing your current income to your potential retirement income isn't exactly the right comparison. Instead, you need to compare the tax rate you'll pay on a Roth contribution today versus the tax rate on traditional retirement account withdrawals in retirement. It's very often the case that you'll pay a lower overall tax rate on withdrawals from a traditional account than you'll pay on Roth contributions today even if you have a higher income in retirement.

Marginal tax rates versus effective tax rates

Before you can understand why it likely makes more sense to use a traditional retirement account versus a Roth account, you must first understand the difference between marginal tax rates and effective tax rates.

Marginal tax rate: the tax rate on your next dollar of income. People that say they're in the 22% income tax bracket are describing their marginal tax rate.Effective tax rate: your total tax bill as a percentage of your income. This number is always lower than the marginal tax rate due to the progressive nature of the U.S. tax system.

Jason Hall did an excellent write up on marginal and effective tax rates that goes into more depth.

For every dollar you contribute to a traditional retirement account, you're reducing your taxable income and saving on taxes at your marginal tax rate. The corollary is that each dollar saved in a Roth account is effectively taxed at your marginal tax rate because you could've saved it in a traditional account.

That's very important to understand, so you might want to reread that last paragraph.

More:Saving enough? 3 questions to answer that will help grow your retirement nest egg

More:401(k) limits: 7 answers to your top retirement plan questions

More:Need a retirement savings boost? 3 painless ways to retire richer

You'd have to spend a lot more in retirement for Roth to make sense

A single person making $60,000 per year is in the 22% tax bracket after taking the $12,000 standard deduction. In order to reach a 22% effective tax rate on a traditional IRA withdrawal, he'd have to have an income of $195,105 in retirement, assuming the same tax code as today.

The math works a little bit better for someone in the 12% tax bracket. Someone making $50,700 per year is right at the top of the 12% bracket after taking the standard deduction. Still, they'd have to withdraw $52,605 from a traditional IRA in retirement for the math to work out in favor of a Roth IRA. That's a 16.4% increase in spending during retirement after factoring out the $5,500 saved in a Roth account during working years.

So, it really depends on how much you spend in retirement. I'm a firm believer of living the life you want as long as you can save for your future at the same time. I don't expect my retirement expenses to increase over my current living expenses. As some expenses like healthcare increase, my housing cost will effectively decrease due to inflation and eventually move a lot closer to $0 after paying off my mortgage.

Assuming you maintain the same standard of living in retirement, your taxes will be lower if you choose a traditional retirement account over a Roth account, all else being equal.

 (Photo: Getty Images)

Don't tilt the math in favor of Roths

Many Roth proponents also like to point out that you can effectively save more in a Roth account than a traditional account, since you're saving the taxes too. And that's technically true, but what if you just saved your tax savings from using a traditional retirement account in a taxable account?

The U.S. government really wants people to invest, so it has very favorable long-term capital gains tax rates. There's even a very generous 0% tax bracket for long-term capital gains. As long as your total taxable income is below $38,700 if your single or $77,400 if you're married, you pay no taxes on long-term capital gains. It's very likely the taxes on your capital gains in retirement will be lower than the taxes on Roth contributions during your working years.

When to use Roths

While I think most people will be better off saving in traditional retirement accounts, there are always exceptions.

If you already have a marginal tax rate of 0%, then you should definitely save money in a Roth account. This actually happened to me recently, when I had a year of relatively low income, saved enough in my traditional 401(k), and had other deductions and credits that resulted in a $0 tax bill. If you have a lot of kids, for example, and you get a lot of tax credits for them, a Roth could work out better for your situation.

At the 10% marginal tax rate, it's a very close call and the tax benefits for traditional contributions are practically nothing for most people. It might make sense to lock in the 10% rate as a hedge against potential tax increases in the future.

If you don't qualify for a traditional IRA deduction, you should put your money in a Roth account. The IRS phases out the IRA deduction as your income increases. The government also prevents you from contributing directly to a Roth IRA if your income gets too high. You can still, however, execute the backdoor Roth with after-tax contributions to your IRA. If you can execute the megabackdoor Roth, you should definitely take advantage of the opportunity.

Saving in a Roth account is better than saving in a taxable account. You'll be able to buy and sell stocks without worrying about capital gains and you'll be able to withdraw the gains tax free regardless of your income in retirement.

Ultimately, every person's situation is different. This article aims to provide a framework for making the Roth versus Traditional decision: compare your marginal tax rate today versus your effective tax rate in retirement. It might require you to do some homework to figure out your financial situation, but it can save you thousands of dollars in taxes over the long run.

For me, it usually makes sense to max out my pre-tax retirement accounts before looking at Roth contributions.

CLOSE

Trade your sunglasses for snowsuits and umbrellas if you want to live in one the three best cities for enjoying your golden years. Buzz60's Sean Dowling has more. Buzz60

The Motley Fool has a disclosure policy.

The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY.

Offer from the Motley Fool: The $16,122 Social Security bonus most retirees completely overlook
If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income. For example: one easy trick could pay you as much as $16,122 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after.�Simply click here to discover how to learn more about these strategies.

Friday, July 6, 2018

Analysts’ Weekly Ratings Changes for Hain Celestial Group (HAIN)

Hain Celestial Group (NASDAQ: HAIN) recently received a number of ratings updates from brokerages and research firms:

7/2/2018 – Hain Celestial Group was downgraded by analysts at ValuEngine from a “sell” rating to a “strong sell” rating. 6/25/2018 – Hain Celestial Group had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc. They now have a $40.00 price target on the stock. They wrote, “We believe this morning��s CEO succession announcement positions HAIN for its next phase.”” 6/25/2018 – Hain Celestial Group had its price target lowered by analysts at Citigroup Inc from $40.00 to $36.00. They now have a “buy” rating on the stock. 6/20/2018 – Hain Celestial Group was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 6/12/2018 – Hain Celestial Group was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating. 6/5/2018 – Hain Celestial Group is now covered by analysts at Deutsche Bank AG. They set a “buy” rating and a $33.00 price target on the stock. 6/2/2018 – Hain Celestial Group was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating. 5/10/2018 – Hain Celestial Group was given a new $30.00 price target on by analysts at Loop Capital. They now have a “hold” rating on the stock. 5/10/2018 – Hain Celestial Group had its “hold” rating reaffirmed by analysts at SunTrust Banks, Inc.. 5/9/2018 – Hain Celestial Group had its price target lowered by analysts at Buckingham Research from $37.00 to $27.00. They now have a “neutral” rating on the stock. 5/9/2018 – Hain Celestial Group had its price target lowered by analysts at BMO Capital Markets from $39.00 to $31.00. They now have a “market perform” rating on the stock. 5/9/2018 – Hain Celestial Group was given a new $38.00 price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock. 5/8/2018 – Hain Celestial Group had its “buy” rating reaffirmed by analysts at Maxim Group. They now have a $40.00 price target on the stock, down previously from $50.00. 5/8/2018 – Hain Celestial Group had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc. They now have a $40.00 price target on the stock. They wrote, “3Q results (incl. HPP which is now classified as discontinued ops) came in significantly below expectations. Much of the miss was driven by higher corp. expense, freight and commodity related headwinds as well as higher marketing investments, all of which we view as transitory. We estimate comparable 3Q EBITDA missed our estimate significantly & revised guidance (incl. HPP) implies 4Q EBITDA ~21% lower than before, ~18% below our est., & ~16% below consensus.”” 5/7/2018 – Hain Celestial Group was given a new $32.00 price target on by analysts at Susquehanna Bancshares Inc. They now have a “hold” rating on the stock.

Shares of Hain Celestial Group opened at $30.28 on Friday, according to MarketBeat. Hain Celestial Group Inc has a 52 week low of $25.41 and a 52 week high of $45.61. The stock has a market capitalization of $3.25 billion, a P/E ratio of 24.82, a P/E/G ratio of 2.81 and a beta of 1.07. The company has a current ratio of 2.79, a quick ratio of 1.83 and a debt-to-equity ratio of 0.39.

Get Hain Celestial Group Inc alerts:

Hain Celestial Group (NASDAQ:HAIN) last announced its quarterly earnings results on Tuesday, May 8th. The company reported $0.37 EPS for the quarter, missing the Zacks’ consensus estimate of $0.47 by ($0.10). Hain Celestial Group had a net margin of 2.81% and a return on equity of 8.32%. The company had revenue of $632.72 million during the quarter, compared to analyst estimates of $746.48 million. During the same quarter last year, the company posted $0.35 EPS. The firm’s quarterly revenue was up 7.5% on a year-over-year basis. equities analysts expect that Hain Celestial Group Inc will post 1.16 earnings per share for the current year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Dynamic Technology Lab Private Ltd acquired a new position in Hain Celestial Group in the 1st quarter valued at about $1,372,000. Summit Trail Advisors LLC grew its position in shares of Hain Celestial Group by 12.5% during the 1st quarter. Summit Trail Advisors LLC now owns 28,408 shares of the company’s stock worth $616,000 after purchasing an additional 3,164 shares in the last quarter. Principal Financial Group Inc. grew its position in shares of Hain Celestial Group by 3.0% during the 1st quarter. Principal Financial Group Inc. now owns 454,320 shares of the company’s stock worth $14,570,000 after purchasing an additional 13,377 shares in the last quarter. Xact Kapitalforvaltning AB grew its position in shares of Hain Celestial Group by 46.3% during the 1st quarter. Xact Kapitalforvaltning AB now owns 12,639 shares of the company’s stock worth $405,000 after purchasing an additional 4,000 shares in the last quarter. Finally, Royal Bank of Canada grew its position in shares of Hain Celestial Group by 0.4% during the 1st quarter. Royal Bank of Canada now owns 1,082,283 shares of the company’s stock worth $34,708,000 after purchasing an additional 4,413 shares in the last quarter. Institutional investors and hedge funds own 89.21% of the company’s stock.

The Hain Celestial Group, Inc manufactures, markets, distributes, and sells organic and natural products. Its grocery products include infant formula; infant, toddler, and kids foods; diapers and wipes; rice and grain-based products; flour and baking mixes; breads, hot and cold cereals, pasta, condiments, cooking and culinary oils, granolas, and cereal bars; canned, chilled fresh, aseptic, and instant soups; Greek-style yogurts; chilies and packaged grains; chocolates; and nut butters, as well as plant-based beverages and frozen desserts, such as soy, rice, oat, almond, and coconut.

Thursday, July 5, 2018

Shoe Carnival, Inc. (SCVL) Expected to Announce Quarterly Sales of $265.90 Million

Equities research analysts forecast that Shoe Carnival, Inc. (NASDAQ:SCVL) will announce sales of $265.90 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Shoe Carnival’s earnings. The lowest sales estimate is $264.80 million and the highest is $267.00 million. Shoe Carnival posted sales of $235.06 million during the same quarter last year, which suggests a positive year over year growth rate of 13.1%. The firm is expected to announce its next quarterly earnings results on Wednesday, August 29th.

On average, analysts expect that Shoe Carnival will report full-year sales of $1.02 billion for the current financial year. For the next financial year, analysts expect that the business will post sales of $1.02 billion per share, with estimates ranging from $1.01 billion to $1.03 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Shoe Carnival.

Get Shoe Carnival alerts:

Shoe Carnival (NASDAQ:SCVL) last posted its quarterly earnings results on Thursday, May 24th. The company reported $0.83 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The company had revenue of $257.40 million during the quarter, compared to the consensus estimate of $261.82 million. Shoe Carnival had a return on equity of 9.61% and a net margin of 2.31%. The business’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period last year, the business earned $0.48 EPS.

Several brokerages have recently weighed in on SCVL. BidaskClub raised Shoe Carnival from a “hold” rating to a “buy” rating in a report on Thursday, May 31st. TheStreet upgraded Shoe Carnival from a “c+” rating to a “b” rating in a research report on Friday, May 25th. Zacks Investment Research upgraded Shoe Carnival from a “hold” rating to a “strong-buy” rating and set a $37.00 target price for the company in a research report on Thursday, May 31st. Pivotal Research set a $31.00 target price on Shoe Carnival and gave the stock a “buy” rating in a research report on Monday, May 28th. Finally, ValuEngine raised Shoe Carnival from a “hold” rating to a “buy” rating in a research note on Saturday, May 26th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Shoe Carnival currently has an average rating of “Buy” and an average price target of $29.50.

SCVL traded up $0.15 during midday trading on Thursday, reaching $32.89. The company’s stock had a trading volume of 146,900 shares, compared to its average volume of 262,089. Shoe Carnival has a twelve month low of $15.07 and a twelve month high of $34.98. The firm has a market capitalization of $526.35 million, a P/E ratio of 22.07, a price-to-earnings-growth ratio of 1.35 and a beta of 0.85.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 27th. Investors of record on Monday, July 9th will be given a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date is Friday, July 6th. Shoe Carnival’s dividend payout ratio is currently 20.13%.

In related news, Director Jeffrey C. Gerstel sold 1,200 shares of the firm’s stock in a transaction on Wednesday, April 11th. The stock was sold at an average price of $24.48, for a total transaction of $29,376.00. Following the completion of the transaction, the director now directly owns 4,893 shares of the company’s stock, valued at approximately $119,780.64. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Kent A. Kleeberger sold 2,142 shares of the firm’s stock in a transaction on Tuesday, May 29th. The stock was sold at an average price of $32.33, for a total value of $69,250.86. Following the transaction, the director now directly owns 16,799 shares of the company’s stock, valued at $543,111.67. The disclosure for this sale can be found here. Company insiders own 22.70% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. MetLife Investment Advisors LLC acquired a new position in Shoe Carnival during the 4th quarter valued at about $110,000. Brandywine Global Investment Management LLC bought a new stake in Shoe Carnival during the 4th quarter valued at $172,000. Allianz Asset Management GmbH bought a new stake in Shoe Carnival during the 1st quarter valued at $219,000. Koch Industries Inc. bought a new stake in Shoe Carnival during the 4th quarter valued at $228,000. Finally, Element Capital Management LLC bought a new stake in Shoe Carnival during the 1st quarter valued at $251,000. Institutional investors own 82.69% of the company’s stock.

Shoe Carnival Company Profile

Shoe Carnival, Inc, together with its subsidiaries, operates as a family footwear retailer in the United States. The company offers various dress, casual, and athletic footwear products for men, women, and children; and accessories, such as socks, belts, shoe care items, handbags, sport bags, backpacks, jewelry, scarves, and wallets.

Get a free copy of the Zacks research report on Shoe Carnival (SCVL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Shoe Carnival (NASDAQ:SCVL)

Wednesday, July 4, 2018

SL Green Realty Corp (SLG) Receives Average Rating of “Hold” from Analysts

Shares of SL Green Realty Corp (NYSE:SLG) have been given an average recommendation of “Hold” by the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, six have given a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $111.54.

A number of equities analysts recently weighed in on the stock. Sandler O’Neill reaffirmed a “buy” rating and issued a $115.00 target price on shares of SL Green Realty in a research note on Monday, April 23rd. ValuEngine lowered shares of SL Green Realty from a “hold” rating to a “sell” rating in a research note on Thursday, May 17th. Zacks Investment Research raised shares of SL Green Realty from a “hold” rating to a “buy” rating and set a $107.00 target price for the company in a research note on Wednesday, April 11th. JPMorgan Chase & Co. reduced their target price on shares of SL Green Realty from $114.00 to $113.00 and set an “overweight” rating for the company in a research note on Tuesday, April 24th. Finally, SunTrust Banks lowered shares of SL Green Realty from a “buy” rating to a “hold” rating and set a $108.00 target price for the company. in a research note on Friday, March 9th.

Get SL Green Realty alerts:

NYSE SLG traded up $0.91 on Tuesday, reaching $101.28. The company had a trading volume of 369,200 shares, compared to its average volume of 987,266. The firm has a market cap of $8.89 billion, a PE ratio of 15.70, a PEG ratio of 2.48 and a beta of 1.08. The company has a current ratio of 2.72, a quick ratio of 2.72 and a debt-to-equity ratio of 0.80. SL Green Realty has a 1-year low of $89.46 and a 1-year high of $107.88.

SL Green Realty (NYSE:SLG) last announced its earnings results on Wednesday, April 18th. The real estate investment trust reported $0.55 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.65 by ($1.10). The company had revenue of $301.70 million during the quarter, compared to analyst estimates of $295.93 million. SL Green Realty had a return on equity of 2.72% and a net margin of 13.36%. SL Green Realty’s revenue for the quarter was down 20.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.57 earnings per share. equities research analysts forecast that SL Green Realty will post 6.75 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 16th. Stockholders of record on Friday, June 29th will be paid a dividend of $0.813 per share. The ex-dividend date is Thursday, June 28th. This represents a $3.25 dividend on an annualized basis and a dividend yield of 3.21%. SL Green Realty’s dividend payout ratio is 50.39%.

In other news, insider Andrew S. Levine sold 15,000 shares of the stock in a transaction dated Tuesday, May 8th. The shares were sold at an average price of $100.23, for a total transaction of $1,503,450.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 3.65% of the company’s stock.

Several hedge funds have recently modified their holdings of SLG. Millennium Management LLC raised its holdings in shares of SL Green Realty by 1,668.9% in the 4th quarter. Millennium Management LLC now owns 492,035 shares of the real estate investment trust’s stock valued at $49,661,000 after purchasing an additional 464,219 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of SL Green Realty by 158.7% in the 1st quarter. JPMorgan Chase & Co. now owns 588,950 shares of the real estate investment trust’s stock valued at $57,027,000 after purchasing an additional 361,279 shares during the period. Alliancebernstein L.P. raised its holdings in shares of SL Green Realty by 71.1% in the 4th quarter. Alliancebernstein L.P. now owns 402,328 shares of the real estate investment trust’s stock valued at $40,607,000 after purchasing an additional 167,207 shares during the period. Nuveen Asset Management LLC raised its holdings in shares of SL Green Realty by 352.2% in the 1st quarter. Nuveen Asset Management LLC now owns 188,005 shares of the real estate investment trust’s stock valued at $18,205,000 after purchasing an additional 146,426 shares during the period. Finally, Madison International Realty Holdings LLC raised its holdings in shares of SL Green Realty by 25.7% in the 1st quarter. Madison International Realty Holdings LLC now owns 646,723 shares of the real estate investment trust’s stock valued at $62,622,000 after purchasing an additional 132,066 shares during the period.

SL Green Realty Company Profile

SL Green Realty Corp., an S&P 500 company and New York City's largest office landlord, is a fully integrated real estate investment trust, or REIT, that is focused primarily on acquiring, managing and maximizing value of Manhattan commercial properties. As of March 31, 2018, SL Green held interests in 118 Manhattan buildings totaling 49.9 million square feet.

Analyst Recommendations for SL Green Realty (NYSE:SLG)

Thursday, June 28, 2018

Short Interest in Polymet Mining Corp (PLM) Rises By 22.8%

Polymet Mining Corp (NYSEAMERICAN:PLM) (TSE:POM) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 1,483,743 shares, a growth of 22.8% from the May 31st total of 1,208,433 shares. Based on an average daily trading volume, of 731,789 shares, the days-to-cover ratio is currently 2.0 days.

A number of large investors have recently added to or reduced their stakes in PLM. Renaissance Technologies LLC boosted its holdings in Polymet Mining by 185.2% in the fourth quarter. Renaissance Technologies LLC now owns 308,600 shares of the basic materials company’s stock valued at $265,000 after purchasing an additional 200,400 shares during the period. Deutsche Bank AG boosted its holdings in Polymet Mining by 174.8% in the fourth quarter. Deutsche Bank AG now owns 297,368 shares of the basic materials company’s stock valued at $255,000 after purchasing an additional 189,168 shares during the period. All Terrain Financial Advisors LLC purchased a new position in Polymet Mining in the fourth quarter valued at $118,000. Finally, Cahill Financial Advisors Inc. purchased a new position in Polymet Mining in the first quarter valued at $168,000.

Get Polymet Mining alerts:

Polymet Mining traded up $0.03, reaching $1.00, during midday trading on Wednesday, MarketBeat.com reports. The company had a trading volume of 600 shares, compared to its average volume of 542,719. Polymet Mining has a 12-month low of $0.58 and a 12-month high of $1.36.

About Polymet Mining

PolyMet Mining Corp. explores for and develops natural resource properties. Its primary mineral property is the NorthMet project that includes NorthMet copper-nickel-precious metals ore body covering an area of approximately 4,300 acres located in northeastern Minnesota. The company was formerly known as Fleck Resources Ltd.

Sunday, June 24, 2018

Visa Takes Over as Dow's Top-Performing Stock

Credit card giant Visa Inc. (NYSE: V) last week took over the top spot as the best performing Dow Jones industrial average stock for the year to date. The stock posted only a slight gain, one of only eight Dow stocks to show some life in what was a down week for the index. Visa shares added just 0.2% last week but have gained 18.7% for the year to date.

The second-best performer among the Dow index equities so far this year is Nike Inc. (NYSE: NKE), which is up 17.39%. That is followed by Microsoft Corp. (NASDAQ: MSFT), up 17.38%, UnitedHealth Group Inc. (NYSE: UNH), up 19.4%, and Boeing Co. (NYSE: BA), up 14.9%. Of the 30 Dow stocks, 11 have managed to post a gain to date in 2018.

The Dow struggled through a tough week and dropped more than 500 points to close at 24,580.89, down about 2%. For the year to date, the consumer discretionary sector has added 12.9%, displacing tech as the best market sector so far this year.

Looking back over the news for the week it’s hard to see any single event that made much difference to Visa’s share price. There wasn’t even any significant economic news that would have moved the stock much.

What does seem to boost investors’ spirits is the robust U.S. economy and Visa’s position to benefit from that economic boomlet. More Americans are working, wages are inching up and the tax cut has put a little more cash in the average person’s wallet. And they’re spending that cash on something other than higher-priced gasoline.

Consumer discretionary companies are now topping the list of best-performing equities sector. Retail sales have been up for the past two months. The link to credit card and financial services companies is not difficult to discern.

So even though Visa’s share price growth was modest, the company appears well-situated as the summer vacation season kicks into high gear. Spending on travel and discretionary goods is likely to rise, and Visa should�get a nice chunk of the action.

Visa’s shares closed up about 0.6% Friday to $135.33, in a 52-week range of $93.19 to $136.69. The consensus 12-month price target on the stock is $144.36, and the forward price-earnings ratio is 25.78.

24/7 Wall St.
General Electric Exits the Dow as Year’s Worst Performing Stock

Friday, June 1, 2018

Roth IRA Conversion: What's the Benefit?

If it's the last week of the month, odds are Alison Southwick and Robert Brokamp are going to amble over to the Motley Fool Answers mailbag to find out what it is their listeners really want to know. And for added gravitas and expertise, they've brought in reinforcements: Naima Barnes, a financial planner with Motley Fool Wealth Management, a sister company of The Motley Fool.

In this segment of the podcast, they tackle one of the fundamental questions about Roth IRA conversions, which is: Why would you want to do one in the first place? In large measure, the answer comes down to taxes -- when you'll pay them, and how much.

Naima Barnes is an employee of Motley Fool Wealth Management, a separate, sister company of The Motley Fool, LLC. The information provided is intended to be educational only, and should not be construed as individualized advice. For individualized advice, please consult a financial professional.

A full transcript follows the video.

This video was recorded on May 29, 2018.

Alison Southwick: Let's get into it. Our first question comes from the Twitters. The question is, "If the conversion of funds from a traditional IRA to a Roth IRA is counted as income and taxed, then what is the benefit of doing this?"

Robert Brokamp: So, whenever you convert money that's in a traditional account to a Roth, that amount gets added to your taxable income. If you convert $10,000 you have to add that $10,000 to your income, so you're going to pay more taxes this year. The benefit is that ideally you are in a lower tax bracket this year and you'll be in a higher tax bracket in retirement. Basically, you're paying taxes today, or prepaying them, really, at a low rate so that you can get a better benefit when you retire.

There are all kinds of calculators on the internet that will help you analyze the situation. I found one at calcxml.com. Just very quickly a little hypothetical, here. Let's say you're 35 and you're in the 12% tax bracket today. You convert that $10,000 to a Roth. Let's say you're in the 22% tax bracket in retirement. What's the difference? Well, if you do the conversion, that account will provide $8,700 a year in retirement. If you don't do the conversion on an after-tax basis, the traditional IRA will just provide $7,500 a year. You're getting more than $1,200 a year in after-tax income by doing the conversion.

Obviously, this takes some assumptions. You don't really know what the future's going to look like, so there are other reasons to do a conversion. One is a traditional IRA or 401(k), you have to take out required minimum distributions at age 70 and a half. The Roth IRA, you do not, so that's another benefit. You can let that money grow a little longer.

Also, it gives you what's called tax diversification. When you're in retirement, if you have a year in which you have high taxes for any reason [maybe you got a lump sum investment of some kind, a big capital gain], you can tap the Roth, then, to counteract being driven up even higher into a higher tax bracket.

One word of caution, though, is let's say you're in a low tax bracket today and you decide that the conversion makes sense. When you do the conversion, that money gets added to your taxable income which could drive you up into a higher tax bracket, so you only want to convert so much so that you stay in the current tax bracket and not get driven up into the next one.

Sunday, May 27, 2018

Why Shares of Hibbett Sports Dropped Today

What happened

Shares of Hibbett Sports (NASDAQ:HIBB) slumped on Friday after the retailer reported lackluster first-quarter results. Hibbett missed analyst expectations across the board, with strong e-commerce sales unable to offset a decline in comparable-store sales. The stock was down about 13.8% at 11:25 a.m. EDT.

So what

Hibbett reported first-quarter revenue of $274.7 million, down 0.4% year over year and $2.65 million below the average analyst estimate. The decline was driven by a 0.3% drop in comparable-store sales and store closings. Hibbett pointed to strong growth in e-commerce sales, which now account for 7% of total sales, as one silver lining in the quarter.

A slumping chart.

Image source: Getty Images.

Earnings per share came in at $1.12, up from $0.97 in the prior-year period but $0.03 lower than analysts were expecting. A lower tax rate and share buybacks were the only reasons for the earnings growth. Gross margin slumped by 0.4 percentage points year over year, while store operating, selling, and administrative costs as a percentage of revenue jumped by 1.3 percentage points. Operating income tumbled 16.2%.

Hibbett CEO Jeff Rosenthal sounded optimistic about the second quarter: "As we start the second quarter, we believe we are well positioned with fresh assortments and easier comparisons as we prepare for the back-to-school season."

Now what

Hibbett maintained its full-year earnings guidance, which calls for earnings per share between $1.65 and $1.95. Despite the decline in margins during the first quarter, the numbers were still solid overall. Gross margin was 35.2%, while operating margin was 10.4%.

Hibbett has $115.8 million of cash and no debt on its balance sheet, putting it in a strong financial position. While investors didn't like the company's results, Hibbett has plenty of time to turn things around.

Saturday, May 26, 2018

Universal Stainless & Alloy Products (USAP) Trading Down 0%

Shares of Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) traded down 0% on Friday . The company traded as low as $24.22 and last traded at $24.53. 505,097 shares were traded during trading, an increase of 1,278% from the average session volume of 36,661 shares. The stock had previously closed at $24.53.

A number of analysts have weighed in on the company. ValuEngine raised Universal Stainless & Alloy Products from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Zacks Investment Research raised Universal Stainless & Alloy Products from a “sell” rating to a “strong-buy” rating and set a $26.00 price objective for the company in a research report on Thursday, January 25th.

Get Universal Stainless & Alloy Products alerts:

The company has a quick ratio of 0.95, a current ratio of 3.97 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $199.00 million, a price-to-earnings ratio of 58.28 and a beta of 0.99.

Universal Stainless & Alloy Products (NASDAQ:USAP) last posted its quarterly earnings data on Wednesday, April 25th. The basic materials company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09. Universal Stainless & Alloy Products had a return on equity of 1.88% and a net margin of 5.46%. The company had revenue of $63.74 million during the quarter. research analysts predict that Universal Stainless & Alloy Products, Inc. will post 1.28 EPS for the current year.

In related news, Chairman Dennis M. Oates acquired 1,059 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was bought at an average cost of $23.61 per share, with a total value of $25,002.99. Following the transaction, the chairman now owns 95,369 shares of the company’s stock, valued at $2,251,662.09. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.60% of the stock is currently owned by company insiders.

Hedge funds have recently modified their holdings of the company. O Shaughnessy Asset Management LLC purchased a new position in shares of Universal Stainless & Alloy Products during the 1st quarter worth approximately $150,000. Wells Fargo & Company MN raised its stake in shares of Universal Stainless & Alloy Products by 195.0% during the 4th quarter. Wells Fargo & Company MN now owns 6,666 shares of the basic materials company’s stock worth $143,000 after buying an additional 4,406 shares in the last quarter. Element Capital Management LLC purchased a new position in shares of Universal Stainless & Alloy Products during the 1st quarter worth approximately $213,000. Tibra Equities Europe Ltd purchased a new position in shares of Universal Stainless & Alloy Products during the 1st quarter worth approximately $421,000. Finally, Wedge Capital Management L L P NC purchased a new position in shares of Universal Stainless & Alloy Products during the 4th quarter worth approximately $364,000. 87.13% of the stock is owned by institutional investors and hedge funds.

About Universal Stainless & Alloy Products

Universal Stainless & Alloy Products, Inc, together with its subsidiaries, manufactures and markets semi-finished and finished specialty steel products in the United States and internationally. The company's products include stainless steel, nickel alloys, tool steel, and various other alloyed steels.

Friday, May 25, 2018

Top 5 Medical Stocks To Own Right Now

tags:SAGE,CYS,STOR,HPP,AGNC,

Daiwa Securities Group Inc. reduced its position in shares of Teleflex (NYSE:TFX) by 32.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,617 shares of the medical technology company’s stock after selling 8,572 shares during the period. Daiwa Securities Group Inc.’s holdings in Teleflex were worth $4,492,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Comerica Bank lifted its position in shares of Teleflex by 0.6% during the fourth quarter. Comerica Bank now owns 35,546 shares of the medical technology company’s stock worth $9,778,000 after purchasing an additional 198 shares in the last quarter. Creative Planning lifted its position in shares of Teleflex by 6.0% during the fourth quarter. Creative Planning now owns 4,119 shares of the medical technology company’s stock worth $1,025,000 after purchasing an additional 234 shares in the last quarter. Osterweis Capital Management Inc. lifted its position in shares of Teleflex by 0.3% during the fourth quarter. Osterweis Capital Management Inc. now owns 90,707 shares of the medical technology company’s stock worth $22,570,000 after purchasing an additional 242 shares in the last quarter. Barometer Capital Management Inc. lifted its position in shares of Teleflex by 3.2% during the fourth quarter. Barometer Capital Management Inc. now owns 8,075 shares of the medical technology company’s stock worth $2,009,000 after purchasing an additional 250 shares in the last quarter. Finally, Ranger Investment Management L.P. lifted its position in shares of Teleflex by 28.2% during the fourth quarter. Ranger Investment Management L.P. now owns 1,217 shares of the medical technology company’s stock worth $303,000 after purchasing an additional 268 shares in the last quarter. 90.47% of the stock is currently owned by institutional investors and hedge funds.

Top 5 Medical Stocks To Own Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors' Opinion:
  • [By ]

    Sage Therapeutics (SAGE) : "Let's wait and see. I can't bless it until I see more from them."

    AbbVie (ABBV) : "I want to stay away from controversy. I like Eli Lilly (LLY) ."

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here's why they did so poorly.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SAGE Therapeutics (SAGE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 5 Medical Stocks To Own Right Now: CYS Investments, Inc.(CYS)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday. Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes. Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21. MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook. Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06. Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd. Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings. PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results. Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook. Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter. Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression. O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit. BioTelemetry,
  • [By Lisa Levin] Gainers Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes. MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook. Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd. Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday. Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings. PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results. O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit. Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70. Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results. BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter. Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter. SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW. Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results. CYS Investments, Inc. (NYSE: CYS)
  • [By Paul Ausick]

    CYS Investments Inc. (NYSE: CYS) traded down 5.6% Thursday and posted a new 52-week low of $6.25 after closing Wednesday at $6.62. The stock’s 52-week high is $8.98. Volume was around 4.6 million, about three �times the daily average. The reported earnings last night. The shares have reversed their drop and are on track to close flat for the day or maybe even up a little.

  • [By Lisa Levin] Gainers Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 22.6 percent to $3.25 in pre-market trading after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression. Mattersight Corporation (NASDAQ: MATR) shares rose 23.2 percent to $2.65 in pre-market trading after the company agreed to be purchased by NICE Ltd. Comstock Resources, Inc. (NYSE: CRK) rose 21.2 percent to $5.77 in pre-market trading after the company disclosed a deal to buy oil & gas properties in North Dakota from Arkoma, Williston Drilling for about $620 million. The company also announced withdrawal of tender offers for outstanding secured notes. Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 13.7 percent to $386.00 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday. Quantenna Communications, Inc. (NASDAQ: QTNA) shares rose 12.6 percent to $14.70 in pre-market trading. Quantenna is expected to release Q1 results on April 30.. BioTelemetry, Inc. (NASDAQ: BEAT) rose 11.1 percent to $37.50 in pre-market trading as the company reported stronger-than-expected earnings for its first quarter. Penn National Gaming, Inc. (NASDAQ: PENN) rose 10.4 percent to $29.00 in pre-market trading after reporting strong Q1 results. O'Reilly Automotive, Inc. (NASDAQ: ORLY) rose 9.8 percent to $250.00 in pre-market trading following upbeat Q1 profit. Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 9.4 percent to $10.62 in pre-market trading as the company reported upbeat results for its first quarter. CYS Investments, Inc. (NYSE: CYS) rose 9.1 percent to $7.22 in pre-market trading after the company agreed to be acquired by Two Harbors Investment Corp (NYSE: TWO). GNC Holdings, Inc. (NYSE: GNC) rose 8.3 percent to $4.18 in pre-market trading after reporting Q1 results. Domino's Pizza, Inc. (NYSE: DPZ) shares rose 7.6 percent to $251.2
  • [By Matthew Frankel]

    Mortgage real estate investment trust CYS Investments (NYSE:CYS) announced today that it had agreed to be acquired by fellow mortgage REIT Two Harbors Investment (NYSE:TWO).

Top 5 Medical Stocks To Own Right Now: STORE Capital Corporation(STOR)

Advisors' Opinion:
  • [By Brian Feroldi, Leo Sun, and Demitrios Kalogeropoulos]

    Want proof? We asked these Motley Fool investors to highlight a dividend stock that pays a higher yield than Verizon. Here's why they picked�Tanger Factory Outlets (NYSE:SKT), Cedar Fair (NYSE:FUN), and�STORE Capital (NYSE:STOR).�

  • [By Shane Hupp]

    Stevens Capital Management LP bought a new position in shares of STORE Capital (NYSE:STOR) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 24,795 shares of the real estate investment trust’s stock, valued at approximately $615,000.

  • [By Lee Jackson]

    STORE Capital Corp. Inc. (NYSE: STOR) is the leader in the acquisition, investment and management of Single Tenant Operational Real Estate, which is its target market. Investors receive a 4.94% yield, and shares traded recently at $24.85. The 52-week range is $19.65 to $26.58. The consensus price target is $27.08.

  • [By Keith Speights]

    Verizon Communications (NYSE:VZ), Store Capital Corporation (NYSE:STOR), and Sanofi (NYSE:SNY) are three Warren Buffett stocks that have especially high dividend yields of more than 4%. What does the Oracle of Omaha like about these stocks -- and are they smart picks for other investors right now?

Top 5 Medical Stocks To Own Right Now: Hudson Pacific Properties, Inc.(HPP)

Advisors' Opinion:
  • [By Chris Lange]

    Hudson Pacific Properties Inc. (NYSE: HPP) was started as a Buy at Merrill Lynch.

    L Brands Inc. (NYSE: LB) was maintained as Overweight at Morgan Stanley and assigned a price target of $56 (versus a $35.22 close).

Top 5 Medical Stocks To Own Right Now: American Capital Agency Corp.(AGNC)

Advisors' Opinion:
  • [By Sean Williams]

    In particular, agency-only mortgage REITs tend to be a considerably safer bet during a rising interest rate environment. This would include Annaly Capital Management, which had $90.6 billion of its $101.8 billion in total assets invested in agency mortgage-backed securities (MBS) as of Dec. 31, 2017, as well as AGNC Investment Corp. (NASDAQ:AGNC), which had $54.8 billion of its $69.3 billion investment portfolio tied up in agency MBSs. Though agency MBSs pay less given that they're protected from default, it allows Annaly Capital Management and AGNC Investment Corp. to lean on leverage to generate income. As of their most recent quarters, Annaly and AGNC sported respective leverage of 6.6-to-1 and 8.2-to-1.�

Thursday, May 24, 2018

Fortinet Inc (FTNT) CEO Ken Xie Sells 50,000 Shares

Fortinet Inc (NASDAQ:FTNT) CEO Ken Xie sold 50,000 shares of the company’s stock in a transaction on Thursday, May 24th. The stock was sold at an average price of $60.51, for a total value of $3,025,500.00. Following the sale, the chief executive officer now owns 12,562,906 shares of the company’s stock, valued at $760,181,442.06. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of Fortinet traded up $1.47, reaching $60.64, during mid-day trading on Thursday, Marketbeat Ratings reports. The stock had a trading volume of 2,527,800 shares, compared to its average volume of 1,659,185. The firm has a market capitalization of $9.88 billion, a PE ratio of 116.62, a P/E/G ratio of 4.12 and a beta of 0.75. Fortinet Inc has a 1-year low of $35.44 and a 1-year high of $60.82.

Get Fortinet alerts:

Fortinet (NASDAQ:FTNT) last announced its quarterly earnings data on Thursday, May 3rd. The software maker reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.09. The business had revenue of $399.00 million for the quarter, compared to analyst estimates of $390.60 million. Fortinet had a return on equity of 14.64% and a net margin of 4.01%. The company’s revenue was up 17.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.17 earnings per share. equities analysts expect that Fortinet Inc will post 0.85 earnings per share for the current year.

A number of equities research analysts recently weighed in on the company. UBS upped their price objective on Fortinet from $64.00 to $67.00 and gave the stock a “buy” rating in a research note on Monday. Barclays upped their price objective on Fortinet from $48.00 to $50.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 6th. Zacks Investment Research upgraded Fortinet from a “hold” rating to a “buy” rating and set a $62.00 price objective for the company in a research note on Wednesday, May 2nd. Monness Crespi & Hardt restated a “buy” rating and set a $56.00 price objective (up from $50.00) on shares of Fortinet in a research note on Wednesday, February 28th. Finally, Citigroup upped their price objective on Fortinet from $45.00 to $56.00 and gave the stock a “neutral” rating in a research note on Monday, April 16th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $54.83.

Hedge funds have recently made changes to their positions in the company. Guggenheim Capital LLC increased its holdings in shares of Fortinet by 147.4% in the fourth quarter. Guggenheim Capital LLC now owns 432,467 shares of the software maker’s stock valued at $18,895,000 after purchasing an additional 257,687 shares during the period. Schwab Charles Investment Management Inc. increased its holdings in shares of Fortinet by 6.3% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 486,700 shares of the software maker’s stock valued at $21,264,000 after purchasing an additional 29,024 shares during the period. Toronto Dominion Bank increased its holdings in shares of Fortinet by 39.6% in the fourth quarter. Toronto Dominion Bank now owns 8,809 shares of the software maker’s stock valued at $385,000 after purchasing an additional 2,499 shares during the period. Thrivent Financial For Lutherans increased its holdings in shares of Fortinet by 4.9% in the fourth quarter. Thrivent Financial For Lutherans now owns 434,802 shares of the software maker’s stock valued at $18,996,000 after purchasing an additional 20,275 shares during the period. Finally, UBS Asset Management Americas Inc. increased its holdings in shares of Fortinet by 6.6% in the fourth quarter. UBS Asset Management Americas Inc. now owns 457,249 shares of the software maker’s stock valued at $19,977,000 after purchasing an additional 28,247 shares during the period. 69.38% of the stock is currently owned by institutional investors and hedge funds.

Fortinet Company Profile

Fortinet, Inc provides broad, automated, and integrated cybersecurity solutions worldwide. It offers FortiGate hardware and software licenses that provide various security and networking functions, including firewall, intrusion prevention, anti-malware, virtual private network, application control, Web filtering, anti-spam, and WAN acceleration; and FortiSandbox technology that delivers proactive detection and mitigation services; and FortiSIEM family of products, which offers a cloud-ready security information and event management solution for enterprises and service providers.

Insider Buying and Selling by Quarter for Fortinet (NASDAQ:FTNT)

Wednesday, May 23, 2018

Insider Buying: Rosehill Resources (ROSE) Director Buys 6,700 Shares of Stock

Rosehill Resources (NASDAQ:ROSE) Director Harry Quarls acquired 6,700 shares of Rosehill Resources stock in a transaction dated Thursday, May 17th. The shares were bought at an average cost of $8.15 per share, with a total value of $54,605.00. Following the transaction, the director now owns 53,189 shares in the company, valued at $433,490.35. The purchase was disclosed in a filing with the SEC, which is available through this link.

Harry Quarls also recently made the following trade(s):

Get Rosehill Resources alerts: On Monday, May 21st, Harry Quarls acquired 10,000 shares of Rosehill Resources stock. The shares were bought at an average cost of $8.11 per share, with a total value of $81,100.00.

Shares of Rosehill Resources traded up $0.06, reaching $8.05, during trading hours on Monday, according to Marketbeat.com. The stock had a trading volume of 43,600 shares, compared to its average volume of 29,936. Rosehill Resources has a 12 month low of $5.52 and a 12 month high of $10.84. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 6.17. The stock has a market cap of $287.87 million, a P/E ratio of -50.31 and a beta of 1.36.

Rosehill Resources (NASDAQ:ROSE) last issued its earnings results on Monday, May 14th. The company reported $2.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $2.06. Rosehill Resources had a return on equity of 69.29% and a net margin of 5.62%. The company had revenue of $55.79 million for the quarter, compared to analysts’ expectations of $49.80 million. analysts expect that Rosehill Resources will post 1.13 EPS for the current year.

Several institutional investors and hedge funds have recently modified their holdings of the stock. Millennium Management LLC lifted its holdings in shares of Rosehill Resources by 61.4% in the 1st quarter. Millennium Management LLC now owns 18,600 shares of the company’s stock worth $109,000 after purchasing an additional 7,075 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Rosehill Resources by 5.2% in the 1st quarter. Wells Fargo & Company MN now owns 155,546 shares of the company’s stock worth $913,000 after purchasing an additional 7,738 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Rosehill Resources by 12.6% in the 4th quarter. BlackRock Inc. now owns 131,055 shares of the company’s stock worth $1,031,000 after purchasing an additional 14,619 shares in the last quarter. Geode Capital Management LLC bought a new position in shares of Rosehill Resources in the 4th quarter worth $406,000. Finally, Quantum Capital Management lifted its holdings in shares of Rosehill Resources by 130.1% in the 1st quarter. Quantum Capital Management now owns 214,442 shares of the company’s stock worth $1,259,000 after purchasing an additional 121,233 shares in the last quarter. Institutional investors own 5.42% of the company’s stock.

Several analysts have recently commented on ROSE shares. ValuEngine raised shares of Rosehill Resources from a “strong sell” rating to a “sell” rating in a research report on Wednesday, April 18th. Eurobank EFG started coverage on shares of Rosehill Resources in a research report on Tuesday, March 6th. They set a “buy” rating and a $12.00 price objective for the company. B. Riley started coverage on shares of Rosehill Resources in a research report on Monday, February 5th. They set a “buy” rating and a $9.50 price objective for the company. Finally, Zacks Investment Research downgraded shares of Rosehill Resources from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, May 1st. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $11.13.

About Rosehill Resources

Rosehill Resources Inc, an independent oil and natural gas company, focuses on the acquisition, exploration, development, and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin. As of December 31, 2016, it operated 20 horizontal and 1 vertical wells in the Permian Basin; and 18 vertical and 21 horizontal wells in the Barnett Shale in the Fort Worth Basin.

Insider Buying and Selling by Quarter for Rosehill Resources (NASDAQ:ROSE)

Tuesday, May 22, 2018

Top 10 Bank Stocks To Buy For 2018

tags:MRTN,RARE,NEM,MGIC,FNSR,NYRT,DCT,URBN,TIF,PCMI,

After many years of growing profits through cost cutting, American corporations are finally embracing organic growth with capital expenditures.

In aggregate that��s good news for the market, but there will be winners and losers, according to analysts at Bank of America Merrill Lynch.

Thanks to a corporate tax windfall there��s been a surge in capex spending by large corporations during the first quarter of this year. It��s likely to persist for some time, say analysts.

Top 10 Bank Stocks To Buy For 2018: Marten Transport, Ltd.(MRTN)

Advisors' Opinion:
  • [By Stephan Byrd]

    Marten Transport (NASDAQ: MRTN) and YRC Worldwide (NASDAQ:YRCW) are both small-cap transportation companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation.

Top 10 Bank Stocks To Buy For 2018: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors' Opinion:
  • [By Todd Campbell]

    A Genentech alumnus, Conner was previously vice president of clinical science at Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biotech that has successfully developed therapies for rare and ultrarare diseases. Prior to that, he was senior medical director at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), another biotech company that's successfully developed drugs for rare diseases.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

Top 10 Bank Stocks To Buy For 2018: Newmont Mining Corporation(NEM)

Advisors' Opinion:
  • [By Joseph Griffin]

    Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.

  • [By Todd Campbell]

    If these reasons have you interested in adding gold mining stocks to your portfolio, a few top companies to consider are Barrick Gold (NYSE:ABX), Randgold Resources (NASDAQ:GOLD), Newmont Mining (NYSE:NEM), Freeport McMoran (NYSE:FCX) and Goldcorp (NYSE:GG). All five could benefit if gold prices rally, so let's learn more about them.

  • [By ]

    Gold miners have fought for their survival over the last several years, cutting new investments in production and trimming costs. Data from Bloomberg shows the average extraction costs at the largest miners has fallen 27% over the last five years. Tom Brady, Chief Economist at Newmont Mining (NYSE: NEM) estimates global gold production will slip by 1% annually over the next several years due to decreased capital spending by miners.

Top 10 Bank Stocks To Buy For 2018: Magic Software Enterprises Ltd.(MGIC)

Advisors' Opinion:
  • [By Lisa Levin]

    Magic Software Enterprises Ltd. (NASDAQ: MGIC) is estimated to report quarterly earnings at $0.14 per share on revenue of $67.07 million.

    Canadian Solar Inc. (NASDAQ: CSIQ) is projected to report quarterly earnings at $0.47 per share on revenue of $1.34 billion.

  • [By Logan Wallace]

    HC Wainwright set a $10.00 target price on Magic Software Enterprises (NASDAQ:MGIC) in a research note released on Thursday morning. The firm currently has a buy rating on the software maker’s stock.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Magic Software Enterprises (MGIC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Bank Stocks To Buy For 2018: Finisar Corporation(FNSR)

Advisors' Opinion:
  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is the�most�shorted stock on the�NASDAQ with short interest of 62.65% according to Highshortnterest.com.

  • [By Paul Ausick]

    Finisar Corp. (NASDAQ: FNSR) traded down about 3.2% Tuesday and posted a new 52-week low of $15.66 after closing Monday at $16.17. The stock’s 52-week high is $29.07. Volume was less than 10% below the daily average of around 4.4 million shares. The company had no specific news.

  • [By Harsh Chauhan]

    Apple is the more immediate catalyst for Lumentum as it is currently the biggest buyer of VCSEL arrays on the market. It is estimated that Apple now supplies�40% of the chipmaker's top line as compared to none at the beginning of 2017. This is because Lumentum became Apple's sole supplier thanks to a reported inability of rival Finisar (NASDAQ:FNSR) to meet�Cupertino's specifications last year. But the iPhone maker didn't want to put all its eggs in one basket.

  • [By ]

    Activist investor Glenn Welling of Engaged Capital LLC, the insurgent investor agitating for changes at TiVo, Rent-a-Center, on Tuesday, May 15, revealed new positions in Aratana Therapeutics Inc. (PETX) , Cross Country Healthcare Inc. (CCRN)  and Finisar Corp. (FNSR)

  • [By Leo Sun]

    That buyout was considered a major blow to Finisar (NASDAQ:FNSR), which was�also reportedly mulling a bid for Oclaro. I'm not saying Finisar will buy Acacia, but the latter's enterprise value of $740 million makes it a feasible takeover target for bigger fiber players.

Top 10 Bank Stocks To Buy For 2018: New York REIT, Inc.(NYRT)

Advisors' Opinion:
  • [By Max Byerly]

    New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.

Top 10 Bank Stocks To Buy For 2018: DCT Industrial Trust Inc(DCT)

Advisors' Opinion:
  • [By Stephan Byrd]

    Daiwa Securities Group Inc. lifted its holdings in DCT Industrial Trust Inc (NYSE:DCT) by 25.5% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 19,700 shares of the real estate investment trust’s stock after purchasing an additional 4,000 shares during the period. Daiwa Securities Group Inc.’s holdings in DCT Industrial Trust were worth $1,110,000 at the end of the most recent quarter.

  • [By ]

    For an "Executive Decision" segment, Cramer spoke with Hamid Moghadam, chairman and CEO of the logistics REIT, Prologis Inc.  (PLD) , which recently announced the acquisition of DCT Industrial Trust (DCT) .

  • [By Joseph Griffin]

    Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of DCT Industrial Trust Inc (NYSE:DCT) by 7.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,570 shares of the real estate investment trust’s stock after acquiring an additional 1,044 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in DCT Industrial Trust were worth $821,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Bank Stocks To Buy For 2018: Urban Outfitters Inc.(URBN)

Advisors' Opinion:
  • [By Chris Lange]

    Urban Outfitters Inc. (NASDAQ: URBN) is scheduled to release its most recent quarterly results after the markets close on Tuesday. The consensus estimates from Thomson Reuters call for $0.63 in earnings per share (EPS) on $1.08 billion in revenue. In the fourth quarter of last year, the retailer said it had EPS of $0.55 and $1.03 billion in revenue.

  • [By Logan Wallace]

    Investors sold shares of Urban Outfitters (NASDAQ:URBN) on strength during trading on Thursday. $17.36 million flowed into the stock on the tick-up and $38.83 million flowed out of the stock on the tick-down, for a money net flow of $21.47 million out of the stock. Of all equities tracked, Urban Outfitters had the 26th highest net out-flow for the day. Urban Outfitters traded up $0.44 for the day and closed at $42.76

  • [By ]

    In the mid-level, Boss said that Urban Outfitters (URBN) is recovering, along with Kohl's Stores (KSS) . He also liked PVH (PVH) and Lululemon Athletica (LULU) .

  • [By Chris Lange]

    Urban Outfitters Inc. (NASDAQ: URBN) also will report its most recent quarterly results on Tuesday. The consensus estimates call for $0.63 in EPS and $1.08 billion in revenue. Shares were last seen trading at $36.48, in a 52-week range of $16.19 to $38.06. The consensus price target is $34.62.

Top 10 Bank Stocks To Buy For 2018: Tiffany & Co.(TIF)

Advisors' Opinion:
  • [By ]

    HSBC's top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%. 

    Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit  CRH (CRH) Luftansa  GlaxosmithKline (GSK) Associated British Foods   Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Tiffany & Co. (NYSE: TIF) which traded down 5% at $97.51. The stock��s 52-week range is $84.15 to $111.44. Volume was 7.8 million compared to the daily average volume of 1.3 million.

  • [By Shane Hupp]

    First Eagle Investment Management LLC trimmed its holdings in shares of Tiffany & Co. (NYSE:TIF) by 0.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,798,751 shares of the specialty retailer’s stock after selling 29,056 shares during the period. First Eagle Investment Management LLC owned 3.06% of Tiffany & Co. worth $370,986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Taylor Cox]

    Notable Earnings

    Tiffany & Co. (NYSE: TIF) Q1 premarket Ralph Lauren Corporation (NYSE: RL) Q4 premarket Target Corporation (NYSE: TGT) Q1 premarket Lowe’s Companies, Inc (NYSE: LOW) Q1 premarket L Brands, Inc (NYSE: LB) Q1 after hours NetApp, Inc (NASDAQ: NTAP) Q4 after hours

    IPOs

  • [By Chris Lange]

    Look for Tiffany & Co.’s (NYSE: TIF) fiscal fourth-quarter report on Friday. The consensus forecast is $1.64 in EPS on $1.31 billion in revenue. Shares last traded at $101.76. The consensus price target is $111.88, and shares have traded between $84.15 and $111.44 in the past 52 weeks.

  • [By JJ Kinahan]

    It’s all retail all the time this week, with Kohl’s Corporation (NYSE: KSS), Target Corporation (NYSE: TGT), Lowe’s Companies, Inc. (NYSE: LOW), Gap Inc. (NYSE: GPS), Foot Locker, Inc. (NYSE: FL), and Tiffany & Co (NYSE: TIF) among the big names scheduled to report. Last week saw mixed signals from retailers, with Macy’s Inc. (NYSE: M) and Walmart Inc. (NYSE: WMT) both delivering impressive results while J.C. Penney Company Inc. (NYSE: JCP) and Nordstrom, Inc. (NYSE: JWN) received poor reviews from the Street. TGT is arguably the biggest one to watch in the days ahead (see more detail below).

Top 10 Bank Stocks To Buy For 2018: PCM, Inc.(PCMI)

Advisors' Opinion:
  • [By Lisa Levin]

    Thursday afternoon, the information technology shares gained 2.42 percent. Meanwhile, top gainers in the sector included PCM, Inc. (NASDAQ: PCMI), up 17 percent, and Advanced Micro Devices, Inc. (NASDAQ: AMD), up 13 percent.

  • [By Shane Hupp]

    PCM (NASDAQ: PCMI) is one of 20 publicly-traded companies in the “Catalog & mail-order houses” industry, but how does it compare to its competitors? We will compare PCM to similar companies based on the strength of its dividends, institutional ownership, valuation, profitability, risk, analyst recommendations and earnings.

  • [By Lisa Levin]

    On Thursday, the information technology shares gained 2.23 percent. Meanwhile, top gainers in the sector included PCM, Inc. (NASDAQ: PCMI), up 17 percent, and Advanced Micro Devices, Inc. (NASDAQ: AMD), up 14 percent.

  • [By Lisa Levin]

    Thursday morning, the information technology shares gained 1.72 percent. Meanwhile, top gainers in the sector included PCM, Inc. (NASDAQ: PCMI), up 17 percent, and Advanced Micro Devices, Inc. (NASDAQ: AMD), up 13 percent.